Nuvation Bio (NUVB) News Today $2.31 +0.06 (+2.67%) Closing price 05/23/2025 03:59 PM EasternExtended Trading$2.31 0.00 (-0.22%) As of 05/23/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NUVB Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Nuvation Bio stockholders approve board members and executive payMay 25 at 3:35 AM | uk.investing.comNuvation Bio’s SWOT analysis: taletrectinib approval could transform stock outlookMay 23 at 10:11 PM | uk.investing.comNorthern Trust Corp Acquires 563,627 Shares of Nuvation Bio Inc. (NYSE:NUVB)Northern Trust Corp grew its holdings in Nuvation Bio Inc. (NYSE:NUVB - Free Report) by 37.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,086,751 shares of the company's stock after purchasing an addiMay 23 at 3:09 AM | marketbeat.comNuvation Bio To Present New Data from Pivotal Clinical Studies of Taletrectinib in Advanced ROS1-Positive Non-Small Cell Lung Cancer at ASCO 2025 Annual MeetingMay 21, 2025 | businesswire.comWexford Capital LP Purchases 294,452 Shares of Nuvation Bio Inc. (NYSE:NUVB)Wexford Capital LP increased its stake in Nuvation Bio Inc. (NYSE:NUVB - Free Report) by 45.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 946,219 shares of the company's stock after acquiring an additionaMay 21, 2025 | marketbeat.comBrokerages Set Nuvation Bio Inc. (NYSE:NUVB) Target Price at $7.83May 21, 2025 | americanbankingnews.comNuvation Bio Inc. (NYSE:NUVB) Receives Average Recommendation of "Buy" from BrokeragesShares of Nuvation Bio Inc. (NYSE:NUVB - Get Free Report) have been assigned a consensus rating of "Buy" from the six brokerages that are covering the company, MarketBeat.com reports. Five investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the compMay 20, 2025 | marketbeat.comNuvation Bio (NYSE:NUVB) Earns "Outperform" Rating from WedbushMay 17, 2025 | americanbankingnews.com4,164,178 Shares in Nuvation Bio Inc. (NYSE:NUVB) Bought by MPM Bioimpact LLCMPM Bioimpact LLC acquired a new stake in Nuvation Bio Inc. (NYSE:NUVB - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 4,164,178 shares of the company's stock, valued at approximately $11May 16, 2025 | marketbeat.comDimensional Fund Advisors LP Cuts Position in Nuvation Bio Inc. (NYSE:NUVB)Dimensional Fund Advisors LP decreased its holdings in Nuvation Bio Inc. (NYSE:NUVB - Free Report) by 26.1% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,227,152 shares of the company's stock after selling 432,720 shares during thMay 16, 2025 | marketbeat.comNuvation Bio to Present Matching-adjusted Indirect Comparison Data for Taletrectinib vs. Entrectinib at ISPOR 2025May 13, 2025 | businesswire.comWedbush Issues Positive Outlook for Nuvation Bio EarningsNuvation Bio Inc. (NYSE:NUVB - Free Report) - Analysts at Wedbush lifted their Q3 2025 earnings per share estimates for Nuvation Bio in a research note issued on Wednesday, May 7th. Wedbush analyst D. Nierengarten now expects that the company will post earnings per share of ($0.18) for the quarteMay 13, 2025 | marketbeat.comNuvation Bio to Participate in Upcoming Investor ConferencesMay 12, 2025 | gurufocus.comNuvation Bio Inc. (NUVB) Q1 2025 Earnings Call TranscriptMay 11, 2025 | seekingalpha.comNuvation Bio Inc. (NYSE:NUVB) Shares Bought by Algert Global LLCAlgert Global LLC grew its position in Nuvation Bio Inc. (NYSE:NUVB - Free Report) by 202.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 871,469 shares of the company's stock after purchasing an addMay 11, 2025 | marketbeat.comNuvation Bio Inc. (NUVB): Among Billionaire David Abrams’ Stock Picks with Huge Upside PotentialMay 9, 2025 | insidermonkey.comNuvation Bio Reports First Quarter 2025 Financial Results and Provides Business UpdateMay 7, 2025 | businesswire.comNuvation Bio Inc. (NYSE:NUVB) Insider Sells $50,000.00 in StockMay 7, 2025 | insidertrades.comSusquehanna Fundamental Investments LLC Takes $572,000 Position in Nuvation Bio Inc. (NYSE:NUVB)Susquehanna Fundamental Investments LLC purchased a new position in shares of Nuvation Bio Inc. (NYSE:NUVB - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 2May 6, 2025 | marketbeat.comNuvation Bio (NYSE:NUVB) Shares Up 9.9% - Should You Buy?Nuvation Bio (NYSE:NUVB) Shares Up 9.9% - Should You Buy?May 5, 2025 | marketbeat.comJPMorgan Chase & Co. Sells 322,798 Shares of Nuvation Bio Inc. (NYSE:NUVB)JPMorgan Chase & Co. cut its holdings in Nuvation Bio Inc. (NYSE:NUVB - Free Report) by 72.9% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 120,115 shares of the company's stock after selling 322,798 shares during the period. JPMorgaMay 5, 2025 | marketbeat.comXTX Topco Ltd Has $28,000 Holdings in Nuvation Bio Inc. (NYSE:NUVB)XTX Topco Ltd decreased its position in Nuvation Bio Inc. (NYSE:NUVB - Free Report) by 92.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 10,585 shares of the company's stock after selling 121,444 sMay 4, 2025 | marketbeat.comNuvation Bio (NUVB) Expected to Announce Earnings on WednesdayNuvation Bio (NYSE:NUVB) will be releasing its Q1 2025 earnings after the market closes on Wednesday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-7-nuvation-bio-inc-stock/)May 2, 2025 | marketbeat.comNuvation Bio to Present at The Citizens Life Sciences ConferenceMay 1, 2025 | businesswire.comRenaissance Technologies LLC Has $1.51 Million Stake in Nuvation Bio Inc. (NYSE:NUVB)Renaissance Technologies LLC trimmed its stake in Nuvation Bio Inc. (NYSE:NUVB - Free Report) by 44.9% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 566,800 shares of the company's stock after sellApril 30, 2025 | marketbeat.comNuvation Bio (NYSE:NUVB) Earns Market Outperform Rating from Analysts at JMP SecuritiesJMP Securities initiated coverage on shares of Nuvation Bio in a research report on Wednesday. They issued a "market outperform" rating and a $6.00 price objective on the stock.April 25, 2025 | marketbeat.comNuvation Bio initiated with an Outperform at Citizens JMPApril 24, 2025 | markets.businessinsider.comJMP Securities Initiates Coverage of Nuvation Bio (NUVB) with Market Outperform RecommendationApril 23, 2025 | msn.comGeode Capital Management LLC Raises Stock Holdings in Nuvation Bio Inc. (NYSE:NUVB)Geode Capital Management LLC raised its holdings in shares of Nuvation Bio Inc. (NYSE:NUVB - Free Report) by 22.9% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 4,951,195 shares of the compaApril 23, 2025 | marketbeat.comNuvation Bio to Report Results for First Quarter 2025 and Provide Business Update on May 7, 2025April 22, 2025 | businesswire.comFederated Hermes Inc. Sells 349,503 Shares of Nuvation Bio Inc. (NYSE:NUVB)Federated Hermes Inc. lowered its stake in Nuvation Bio Inc. (NYSE:NUVB - Free Report) by 95.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 18,439 shares of the company's stock after selApril 21, 2025 | marketbeat.comNuvation Bio (NYSE:NUVB) Shares Down 6.4% - Should You Sell?Nuvation Bio (NYSE:NUVB) Stock Price Down 6.4% - Here's WhyApril 18, 2025 | marketbeat.comIs Nuvation Bio Inc. (NYSE:NUVB) the Best Biotech Penny Stock to Buy According to Hedge Funds?April 16, 2025 | insidermonkey.comNuvation Bio Inc. (NYSE:NUVB) Shares Acquired by Fmr LLCFmr LLC lifted its position in Nuvation Bio Inc. (NYSE:NUVB - Free Report) by 54.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 45,285,572 shares of the company's stock after acquiring an additional 16,April 16, 2025 | marketbeat.comIs Nuvation Bio Inc. (NUVB) the Top Healthcare Stock to Buy According to Billionaire David Einhorn?April 14, 2025 | msn.comNuvation Bio Inc. (NYSE:NUVB) Shares Acquired by Vanguard Group Inc.Vanguard Group Inc. increased its stake in shares of Nuvation Bio Inc. (NYSE:NUVB - Free Report) by 45.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 15,732,567 shares of the company's stock after buApril 14, 2025 | marketbeat.comInsider Buying: Nuvation Bio Inc. (NYSE:NUVB) CEO Purchases 200,000 Shares of StockNuvation Bio Inc. (NYSE:NUVB - Get Free Report) CEO David Hung acquired 200,000 shares of Nuvation Bio stock in a transaction on Friday, April 4th. The shares were bought at an average cost of $1.66 per share, with a total value of $332,000.00. Following the completion of the transaction, the chief executive officer now owns 58,481,054 shares of the company's stock, valued at approximately $97,078,549.64. This trade represents a 0.34 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.April 11, 2025 | marketbeat.comDavid Hung Acquires 300,000 Shares of Nuvation Bio Inc. (NYSE:NUVB) StockNuvation Bio Inc. (NYSE:NUVB - Get Free Report) CEO David Hung bought 300,000 shares of the stock in a transaction that occurred on Monday, April 7th. The shares were bought at an average cost of $1.62 per share, with a total value of $486,000.00. Following the completion of the transaction, the chief executive officer now owns 58,781,054 shares in the company, valued at $95,225,307.48. The trade was a 0.51 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.April 10, 2025 | marketbeat.comNuvation Bio Inc. (NYSE:NUVB) CEO David Hung Acquires 200,000 SharesApril 10, 2025 | insidertrades.comTuesday’s Insider Activity: Key Buys and Sells in US StocksApril 9, 2025 | investing.comNuvation Bio Inc. (NUVB): Among Stocks Under $10 that Will TripleApril 9, 2025 | msn.comNuvation Bio (NYSE:NUVB) Reaches New 1-Year Low - What's Next?Nuvation Bio (NYSE:NUVB) Sets New 52-Week Low - Here's WhyApril 9, 2025 | marketbeat.comDavid Hung Buys 300,000 Shares of Nuvation Bio Inc. (NYSE:NUVB) StockApril 9, 2025 | insidertrades.comNuvation Bio (NYSE:NUVB) Stock Price Up 5.4% - Here's What HappenedNuvation Bio (NYSE:NUVB) Trading Up 5.4% - Here's What HappenedApril 4, 2025 | marketbeat.comNuvation Bio to Present at the Jones Healthcare and Technology Innovation ConferenceApril 2, 2025 | businesswire.comNuvation Bio (NYSE:NUVB) Sets New 12-Month Low - Should You Sell?Nuvation Bio (NYSE:NUVB) Reaches New 12-Month Low - Here's What HappenedApril 1, 2025 | marketbeat.comNuvation Bio (NYSE:NUVB) Receives "Outperform" Rating from WedbushWedbush restated an "outperform" rating and set a $5.00 price objective on shares of Nuvation Bio in a research report on Thursday.March 28, 2025 | marketbeat.comNuvation Bio Inc. (NYSE:NUVB) Stock Position Boosted by Charles Schwab Investment Management Inc.Charles Schwab Investment Management Inc. grew its stake in shares of Nuvation Bio Inc. (NYSE:NUVB - Free Report) by 39.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,945,983 shares of the company'sMarch 26, 2025 | marketbeat.comInsider Stock Buying Reaches US$720.1k On Nuvation BioMarch 25, 2025 | uk.finance.yahoo.comNuvation Bio to Present New Nonclinical Data for Taletrectinib at the American Association for Cancer Research Annual Meeting 2025March 25, 2025 | businesswire.com Get Nuvation Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for NUVB and its competitors with MarketBeat's FREE daily newsletter. Email Address NUVB Media Mentions By Week NUVB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NUVB News Sentiment▼0.890.77▲Average Medical News Sentiment NUVB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NUVB Articles This Week▼74▲NUVB Articles Average Week Get Nuvation Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for NUVB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Viking Therapeutics News Metsera News Akero Therapeutics News Alvotech News Catalyst Pharmaceuticals News Crinetics Pharmaceuticals News Scholar Rock News Merus News MorphoSys News Protagonist Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:NUVB) was last updated on 5/25/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredPrepare now for May 31 eventPrepare now for May 31 event Circle May 31 on your calendar This man grew up in a trailer in New Mexico. To...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuvation Bio Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuvation Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NUVB Stock Free NUVB Stock Alerts